Last reviewed · How we verify
NCT04880681
Evaluation of Length and Quality of Prostate Biopsies Taken by a New Biopsy Needle
NA trial testing Novel needle (18 G, 25 cm with 19 mm sample notch) in a new actuator. in Prostate Cancer (Diagnosis) in 60 participants. Status unknown.
30 December 2023
Quick facts
| Lead sponsor | Region Skane |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 60 |
| Start date | 17 May 2021 |
| Primary completion | 30 December 2023 |
| Estimated completion | 28 February 2024 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Novel needle (18 G, 25 cm with 19 mm sample notch) in a new actuator.
- Standard Tru Cut biopsy needle (Argon 18G, 25 cm biopsy needle with a 19 mm sample notch) in a standard actuator (Möller Medical Blue RBG-1000-10-1000)
Conditions studied
- Prostate Cancer (Diagnosis) — all drugs for Prostate Cancer (Diagnosis) →
Sponsor
Region Skane — full company profile →
Who can join
40 and older, male only, with Prostate Cancer (Diagnosis). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Patient-blinded randomized controlled trial evaluating length and quality of prostate biopsies taken by a novel biopsy needle.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04880681
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prostate Cancer (Diagnosis)
Currently open trials in the same condition.
- NCT07144228 — Validation of a Platelet Proteomic Assay for Diagnosing and Monitoring Prostate Cancer · recruiting
- NCT07398690 — INSIGHT-PCa: MRI- and PHI-Guided Risk-Adapted Strategy for Prostate Cancer Diagnosis · NA · recruiting
- NCT07460843 — Comparison of TB+PB and TB+6SB for Prostate Cancer Diagnosis · NA · recruiting
- NCT07369570 — Evolution of Lesions in Repeated Biparametric Prostate Magnetic Resonance Imaging · NA · recruiting
- NCT07243834 — Assessing a Digital Exercise Intervention for Health Outcomes and Engagement in Regular Exercise · NA · recruiting
Other Region Skane trials
Trials by the same sponsor.
- NCT07511673 — The Study is a Randomised Clinical Trial (RCT) to Test if Preoperative Dental Screening is Superior to no Preoperative D · NA · not yet recruiting
- NCT07169747 — Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young · Phase 2 · recruiting
- NCT07494669 — Proteomics and Physiological Parameters Predicting Complications After Colorectal Cancer Surgery · not yet recruiting
- NCT07462351 — System-integrated Point-of-Care Ultrasound in Breast Cancer Screening · NA · recruiting
- NCT06975696 — Fusion Imaging in Endovascular Thrombectomy for Acute Ischemic Stroke · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04880681 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Skane
- Last refreshed: 1 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04880681.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing